Senate breaks for recess, delaying vote on ICE funding, DNC releases 'autopsy' of 2024 presidential election, a look at Trump's political -- and personal -- interest in Cuba.
The Commission of Fine Arts has given a design for a massive arch in Washington, D.C., its final approval, even though it's missing some visual components.
Eli Lilly announced clinical trial results for retatrutide, its next gen obesity drug. The drug helped study participants lose 70 lbs over 80 weeks, making it more powerful than Zepbound and Wegovy.